6JQ-30593-41035
2 vaccinations
3 coded responses
21 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 841 / UT
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Pfizer-BioNTech
- 2020-12-28
- 2020-12-29
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
-
2021-01-04
Health check-in — day 7, dose 1Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-04
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-11
- 2021-01-18
-
2021-01-22
Dose 2 — Pfizer-BioNTech
- 2021-01-25
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-02-05
- 2021-02-12
-
2021-02-19
Survey response — day 28, dose 2MedDRA: Headache, Respiratory tract congestion, Rhinorrhoea — Feeling: GoodFree text: Runny nose, congestion, headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-26
Survey response — day 35, dose 2MedDRA: Fatigue, Nausea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Nausea, fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-05
- 2021-04-25
- 2021-07-23
-
2022-01-25
Survey response — 12 months, dose 2MedDRA: Fatigue, Iron deficiency anaemia, Upper-airway cough syndrome — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: iron deficiency anemia, fatigue related to anemia, post-nasal dripMedDRA releases: 2024-11 · check-in free text available
-
2022-01-25
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-26
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Pfizer-BioNTech | |
| 2 | 2021-01-22 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-04 | priority 2/3 | |
| 2022-01-25 | Successful 2022-01-26 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 4 — day 28, dose 2
Symptoms: Runny nose, congestion, headache
Release 4 — day 35, dose 2
Symptoms: Nausea, fatigue
Release 11 — 12 months, dose 2
Symptoms: iron deficiency anemia, fatigue related to anemia, post-nasal drip
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Iron deficiency anaemia | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release